217 related articles for article (PubMed ID: 6968337)
1. Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes.
Fernandez-Cruz E; Woda BA; Feldman JD
J Exp Med; 1980 Oct; 152(4):823-41. PubMed ID: 6968337
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of a chemically-induced sarcoma in rats: characterization of the effector T cell subset and nature of suppression.
Fernandez-Cruz E; Gilman SC; Feldman JD
J Immunol; 1982 Mar; 128(3):1112-7. PubMed ID: 6460058
[TBL] [Abstract][Full Text] [Related]
3. Altered levels of mononuclear leukocytes in tumor-bearing rats: decrease of helper T lymphocytes and increase of suppressor cells.
Fernandez-Cruz E; Gilman SC; Feldman JD
J Immunol; 1982 Sep; 129(3):1324-8. PubMed ID: 6213711
[TBL] [Abstract][Full Text] [Related]
4. W3/25+ T cells mediate the induction of immunologic unresponsiveness in enhanced rat recipients of cardiac allografts.
Padberg WM; Kupiec-Weglinski JW; Lord RH; Araneda DH; Tilney NL
J Immunol; 1987 Jun; 138(11):3669-74. PubMed ID: 2953786
[TBL] [Abstract][Full Text] [Related]
5. Membrane phenotype of the rat cytotoxic T lymphocyte.
Gilman SC; Rosenberg JS; Feldman JD
J Immunol; 1982 Sep; 129(3):1012-6. PubMed ID: 6980913
[TBL] [Abstract][Full Text] [Related]
6. In vivo elimination by specific effector cells of an established syngeneic rat moloney virus-induced sarcoma.
Fernandez-Cruz E; Halliburton B; Feldman JD
J Immunol; 1979 Oct; 123(4):1772-7. PubMed ID: 158055
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated cytotoxicity to moloney sarcoma in syngeneic and allogeneic rats.
Veit BC; Feldman JD
Int J Cancer; 1975 Mar; 15(3):367-76. PubMed ID: 1079791
[TBL] [Abstract][Full Text] [Related]
8. T-lymphocyte heterogeneity in the rat: separation of distinct rat T-lymphocyte populations which respond in syngeneic and allogeneic mixed lymphocyte reactions.
Sopori ML; Cohen DA; Cherian S; Roszman TL; Kaplan AM
Cell Immunol; 1984 Aug; 87(1):295-303. PubMed ID: 6204777
[TBL] [Abstract][Full Text] [Related]
9. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
[TBL] [Abstract][Full Text] [Related]
10. Interactions between T helper cells and dendritic cells during the rat mixed lymphocyte reaction.
Green J; Jotte R
J Exp Med; 1985 Nov; 162(5):1546-60. PubMed ID: 2932518
[TBL] [Abstract][Full Text] [Related]
11. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
Plata F; Jongeneel V; Cerottini JC; Brunner KT
Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
[TBL] [Abstract][Full Text] [Related]
12. Distinct T-cell proliferative responses to 13762A rat mammary adenocarcinoma and derived clones.
Christensen ND; Kreider JW; Bartlett GL; Horetsky RL
Cell Immunol; 1986 Feb; 97(2):433-45. PubMed ID: 3091274
[TBL] [Abstract][Full Text] [Related]
13. Phenotype analyses and cellular mechanisms of the pre-effector T-lymphocyte response to a progressive syngeneic murine sarcoma.
Sakai K; Chang AE; Shu SY
Cancer Res; 1990 Jul; 50(14):4371-6. PubMed ID: 2114215
[TBL] [Abstract][Full Text] [Related]
14. In vivo treatment with W3/13 (anti-pan T) but not with OX8 (anti-suppressor/cytotoxic T) monoclonal antibodies impedes the development of adjuvant arthritis in rats.
Larsson P; Holmdahl R; Dencker L; Klareskog L
Immunology; 1985 Nov; 56(3):383-91. PubMed ID: 2934315
[TBL] [Abstract][Full Text] [Related]
15. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors.
Biasi G; Saggin L; Dazzi F; De Rossi A; Collavo D
J Immunol; 1983 Mar; 130(3):1447-50. PubMed ID: 6185589
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Ia+ reticulum cell sarcoma (RCS) growth in syngeneic SJL/J mice. I. Inhibition of tumor growth by passive administration of L3T4 monoclonal antibody before or after tumor inoculation.
Ohnishi K; Bonavida B
J Immunol; 1987 Jun; 138(12):4524-9. PubMed ID: 2953807
[TBL] [Abstract][Full Text] [Related]
17. Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations.
Schluesener HJ; Wekerle H
J Immunol; 1985 Nov; 135(5):3128-33. PubMed ID: 2413113
[TBL] [Abstract][Full Text] [Related]
18. Resurgence of killing and in vivo protection mediated by lymphocytes cultured from lymph nodes draining Moloney sarcomas.
Gillespie GY; Hansen CB; Russell SW
Br J Cancer; 1978 Sep; 38(3):365-74. PubMed ID: 81673
[TBL] [Abstract][Full Text] [Related]
19. A comparison of membrane markers on rat cytotoxic cells.
Cantrell DA; Robins RA; Baldwin RW
Immunology; 1983 May; 49(1):139-46. PubMed ID: 6220963
[TBL] [Abstract][Full Text] [Related]
20. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.
Mizuochi T; Ono S; Malek TR; Singer A
J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
